93 related articles for article (PubMed ID: 2465738)
1. [Local chemotherapy of cancer. Intrathecal administration].
Nagai M
Gan To Kagaku Ryoho; 1989 Feb; 16(2):156-64. PubMed ID: 2465738
[TBL] [Abstract][Full Text] [Related]
2. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
3. [Current status of interferon therapy on malignant brain tumor].
Nagai M; Arai T; Kohno S; Iizuka E
Gan No Rinsho; 1983 May; 29(6):608-15. PubMed ID: 6876429
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic one-compartment model using neocarzinostain as a prototype drug and its clinical application to chemotherapy for brain tumor. Part II. A clinical trial with selected protocol].
Matsukado Y; Maeda H; Uemura S; Kuratsu J; Sonoda H
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1933-41. PubMed ID: 6223589
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration.
Clayton J; Vloeberghs M; Jaspan T; Walker D; MacArthur D; Grundy R
Acta Neurochir (Wien); 2008 Jul; 150(7):709-12. PubMed ID: 18401539
[TBL] [Abstract][Full Text] [Related]
6. Local application of interferon to malignant brain tumors.
Nagai M; Arai T; Kohno S; Kohase M
Tex Rep Biol Med; 1981-1982; 41():693-8. PubMed ID: 7052705
[No Abstract] [Full Text] [Related]
7. Three-year recurrence-free survival in a patient with recurrent medulloblastoma after resection, high-dose chemotherapy, and intrathecal Yttrium-90-labeled DOTA0-D-Phe1-Tyr3-octreotide radiopeptide brachytherapy.
Beutler D; Avoledo P; Reubi JC; Mäcke HR; Müller-Brand J; Merlo A; Kühne T
Cancer; 2005 Feb; 103(4):869-73. PubMed ID: 15641034
[TBL] [Abstract][Full Text] [Related]
8. [Interferon therapy for brain tumor patients (author's transl)].
Ueda S; Hirakawa K; Suzuki K; Nakagawa Y; Ibayashi N; Kishida T
No Shinkei Geka; 1982 Feb; 10(2):149-54. PubMed ID: 6174892
[TBL] [Abstract][Full Text] [Related]
9. [Interferon therapy for malignant brain tumors-present and future (author's transl)].
Nagai M; Arai T
No Shinkei Geka; 1982 May; 10(5):463-76. PubMed ID: 6180343
[No Abstract] [Full Text] [Related]
10. [Efficacy of interferon-beta and interleukin-2 as cytokines for malignant brain tumor treatment].
Shitara N; Nakamura H; Genka S; Takakura K
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3235-44. PubMed ID: 3318704
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics and toxicity of intrathecal administration of recombinant interleukin 2].
Miyatake S; Yamashita J; Tokuriki Y; Yamasaki T; Nishihara T; Handa Y; Sugama K; Tsubai F; Hazama T; Handa H
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2393-8. PubMed ID: 3488031
[TBL] [Abstract][Full Text] [Related]
12. [Intrathecal distribution of ACNU by various modes of its administration analyzed by HPLC and autoradiography].
Hori T; Hirao J; Okamoto H; Nishiyama M; Tanaka S; Muraoka K; Tabuchi F; Tatsuhara T; Nakajima E
No To Shinkei; 1991 Sep; 43(9):833-41. PubMed ID: 1742091
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of malignant brain tumors by the intrathecal administration of BAR (EUdR-antimetabolite-radiation)].
Takakura K; Matsutani M; Koyama Y; Sing OK
No To Shinkei; 1972 May; 24(5):585-93. PubMed ID: 4340910
[No Abstract] [Full Text] [Related]
14. [Correlation of serial MRI and histological findings following intra-tumor local chemotherapy for malignant brain tumor].
Shimura T; Nakazawa S; Takahashi H; Node Y; Tamai J; Kumazaki T
Gan To Kagaku Ryoho; 1994 Feb; 21(2):209-18. PubMed ID: 8311491
[TBL] [Abstract][Full Text] [Related]
15. Local administration of interferon for malignant brain tumors.
Nakagawa Y; Hirakawa K; Ueda S; Suzuki K; Fukuma S; Kishida T; Imanishi J; Amagai T
Cancer Treat Rep; 1983 Sep; 67(9):833-5. PubMed ID: 6688376
[TBL] [Abstract][Full Text] [Related]
16. Therapy of malignant brain tumors: an update on progress.
Wilson CB; Gutin PH
Tex Med; 1980 Jan; 76(1):40-3. PubMed ID: 7352321
[No Abstract] [Full Text] [Related]
17. [Diagnostic value of neuron specific enolase (NSE) in the cerebrospinal fluid of malignant brain tumor with intrathecal metastasis].
Miyagami M; Tazoe M; Tsubokawa T
No To Shinkei; 1989 Oct; 41(10):1021-7. PubMed ID: 2605041
[TBL] [Abstract][Full Text] [Related]
18. [Meningeal gliomatosis--clinical features and results of treatment].
Arita N; Hayakawa T; Mogami H; Ushio Y
Gan No Rinsho; 1989 Sep; 35(11):1308-12. PubMed ID: 2478733
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of acute leukemias in adults. V. The effect of intrathecal cytostatic therapy on leukemic changes in the central nervous system].
Swencz-Szczepanik K; Pawelski S; Maj S; Królikiewicz H; Kaczyńska D; Koszyk E; Apel D
Acta Haematol Pol; 1981; 12(3-4):161-9. PubMed ID: 6952736
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid-disseminated meningioma.
Chamberlain MC; Glantz MJ
Cancer; 2005 Apr; 103(7):1427-30. PubMed ID: 15690330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
